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Background
To describe patients with cognitive difficulties without criteria diagnosis for dementia, Flicker et al. 1 coined the term Mild Cognitive Impairment (MCI) with the idea that this concept could help in the early prediction of the development of dementia. However, MCI defines a syndrome -whose definition has been revised and changed several times since 1991 2-4 -and may be the consequence of different diseases with distinct aetiologies. Consequently, some authors have emphasized the need to clearly characterize the underlying disorder (i.e.
Alzheimer's Disease (AD), vascular dementia...) 5, 6 . This characterization could facilitate predicting the clinical progression of the disease and promote the development of specific therapeutic approaches at an early stage of the disease 6 .
In this context, the measurement of cognitive changes has two main uses. First, this measure could help to identify subjects with prodromal-AD (i.e. symptomatic pre-dementia phase of AD or "MCI due to AD" 6 ). Indeed, a working group has recently highlighted the importance of measuring cognitive change for the diagnosis of "MCI due to AD" (i.e. prodromal-AD) stating as a diagnostic criterion that it -provides evidence of longitudinal decline in cognition‖ 7 . The second use is to enable the follow-up of patients with prodromal-AD, either in a clinical care context, or in intervention trials with cognitive change as a primary outcome to assess the effects of drugs at an early stage of AD [8] [9] [10] .
Yet, in all of these situations, there is currently no recommendation concerning the choice of neuropsychological tests to be used. In order to be informative for the identification or the follow-up of subjects with prodromal-AD, a neuropsychological test must fulfill some requirements. First, selected tests have to be markers of the evolution of the disease, and thus have to explore the cognitive domains which are affected in the course of the different stages of the disease. Secondly, the tests have to be able to measure cognitive changes in the range of cognitive levels of the targeted population 8 . This capacity can be limited by the metrological Cognitive change in prodromal AD 5 properties of neuropsychological tests (i.e. floor and ceiling effects, curvilinearity: sensitivity to detect cognitive changes varying according to the initial cognitive level). These points can be analyzed using a recently published statistical model which allows the study of metrological properties by modeling a latent cognitive factor which is the common cognitive part measured by the neuropsychological tests 11 .
This work aims to investigate the sensitivity of a large set of neuropsychological tests frequently used in subjects with MCI, to measure cognitive changes due to prodromal-AD; and to describe and compare the metrological properties of these tests. This comparison will aid in selecting a restricted number of psychometric tests for the longitudinal identification and followup of subjects with prodromal-AD.
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Methods

Study population
Data came from the PRE-AL Study (PREdiction of ALzheimer's disease) 12 16 . Patients with focal lesions in cerebral imaging, or documented depressive symptoms or with other medical conditions, which could interfere with memory performance or follow-up, were excluded. Each subject signed an informed consent form once the nature of the procedures had been fully explained. The study was approved by the Ethics Committee of the -La Salpêtrière‖ Hospital.
Out of the 251 participants included in the PREAL study, patients who had had no followup (n=17), those with only one visit at 6 months (n=13), and patients with no measurements for any of the neuropsychological tests during their follow-up (n=3), were excluded from our analyses. As AD was the primary outcome of the study, patients who converted to a non-AD dementia (n=6) were excluded from further statistical analyses. Finally, the present analyses were carried out on a total of 212 participants.
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Data collection
Dementia diagnosis and definition of prodromal-AD:
Patients were seen every 6 months for 3 years At each visit, clinical assessment included the recording of all medical events, current treatment, and complete neurologic examination.
Activities of daily life were rated with the IADL scale during an interview with the patient and a knowledgeable collateral source (a spouse or a child) 15 Memory complaint was assessed by a specific questionnaire 17 . The Clinical Dementia Rating scale (CDR) was completed at each visit during follow-up 18 . During the follow-up, when patient meets the clinical DSM-III-R 16 criteria for dementia and/or the score of 1 at the CDR scale, he was considered as "converted" to dementia. In order to minimize intercenter variability, all clinical records were reviewed by an Expert Committee composed of neurologists (n=3), neuropsychologists (n=3), geriatricians (n=3), and psychiatrists (n=3). They re-examined whether clinical criteria for dementia were satisfied using DSM-III-R criteria 16 and classified the patient as AD using the NINCDS-ADRDA Criteria 19 . Patients who converted to AD during the 3-year follow-up were retrospectively classified as patients with prodromal-AD, other subjects were designated as MCI-non AD.
Assessment of neuropsychological performance:
All subjects were tested at inclusion and annually using a standardized neuropsychological battery. In the event of a suspected conversion, the patient underwent an additional neuropsychological evaluation 6 months later. Six cognitive domains commonly affected by ageing and AD were assessed using 13 scores 20-27 described in 
Results
Out of the 212 MCI participants included in the present analyses, 57 converted to AD during the 3-year follow-up (figure 2) and were retrospectively classified as patients with prodromal-AD. The characteristics of these 212 participants are detailed in Table 2 .
Sensitivity of the tests to detect cognitive changes due to prodromal-AD
As shown in Table 3 , older age was associated with both a lower latent cognitive level at baseline (β=-0.081 units of LCP at baseline per year of age p<0.01) and a steeper latent cognitive decline (steeper decline of β=-0.010 units of LCP per years of follow-up per year of age p<0.01).
A higher educational level was associated with a higher latent cognitive level at baseline, but not with a slower latent cognitive decline. Gender was neither associated with latent cognitive level at baseline, nor with a steeper latent cognitive decline. As expected, cognitive change over time Each of these shapes highlighted a different sensitivity pattern for cognitive change over time.
Tests with a concave shape are more sensitive to cognitive change at low rather than at high levels of cognition. Exploring the low levels of cognition and the floor effect: Despite their high sensitivity to cognitive change at low levels of cognition, the four tests with a concave shape do not present the same ability to detect changes at low levels of cognition. While the FCSRT (total-recall score)
can explore low and very low levels of cognition, the shape of the SDOT is quite vertical below -5 units of LCP, revealing the inability of the SDOT to discriminate major cognitive impairment.
Among other tests, the two TMTs showed horizontal shapes in the lowest range of the LCP. This illustrates the floor effect of these tests: minimum values of the tests are reached for a medium LCP value.
Exploring the high levels of cognition and the ceiling effect:
The horizontal shape of total-recall (FCSRT) in high cognitive levels underlines the ceiling effect of this test, and suggests that it is not appropriate to assess cognitive changes in subjects with medium and high cognitive levels.
Among the other tests, only the free-recall (FCSRT) and the verbal-fluency (category) cover the highest values of the LCP (+5.0 to +10.0) and can actually discriminate changes in these high cognitive levels.
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Discussion
In this clinical prospective study of 212 MCI individuals, we provide rational explanations for selecting neuropsychological tests for the longitudinal identification and follow-up of subjects with prodromal-AD. These explanations are based on the analysis of the sensitivity of neuropsychological tests to detect cognitive changes due to prodromal-AD; and on the description of the metrological properties of these tests (i.e. variable sensitivity to cognitive change, floor and ceiling effect).
A major result of this study is the identification of tests that are sensitive to the cognitive change due to prodromal-AD. Some tests present a poor sensitivity to cognitive change and seem, therefore, of limited interest in the context of research or clinical care for a longitudinal followup, namely Baddeley's double task, the TMT-B and the WAIS-Similarities. Conversely, among the thirteen scores analyzed, six showed a significant decrease over time in the prodromal-AD patients, and a substantial difference in their evolution compared with MCI non-AD subjects: the 3 FCSRT scores, the semantic verbal-fluency, the DENO100 and the SDOT. These results are consistent with the neuroanatomic distribution of histopathological abnormalities reported in the mildest stages of AD which overlaps, at least partially, with the regions implicated in these tests.
For example, the neuropathological changes in the early stage of AD begin primarily in medial temporal regions (hippocampus, entorhinal cortex) 31 which are known to be critical for episodic memory function. Consequently, an impaired ability to learn and retain new information (i.e. an episodic memory deficit) is usually the earliest and most prominent feature of AD 32 . The decrease over time of both free-recall and total-recall scores (FCSRT) is therefore consistent with the aggravation of the amnesic syndrome of the medial temporal type 12 . Among other tests, the observed decline of the verbal-fluency (category) test and the DENO100 illustrates the early impairment of access to semantic memory, due to the temporal neocortical damage that occurs in AD 33 . The greater impairment in semantic fluency rather than in letter fluency has been
Cognitive change in prodromal AD 14 previously reported in Mild AD 34, 35 . A potential limitation of this study is that it included subjects with MCI defined according criteria dating from 1999 2 . The use of other criteria to define MCI, or the carrying out of a similar study in the general population, could have led to different results. Another point is that subjects were followed over a limited period of three years, and it is possible that some AD occurred after the third years of follow-up. However, considering the decreasing incidence of AD during the follow-up, with only 5 cases diagnosed during the last visit (Figure 2) , it is likely that this number is low and that this information bias is minimal.
With regards to the metrological properties of the tests, our results suggest a potential interest of selecting neuropsychological tests for a longitudinal follow-up according to the initial cognitive level of the target population (in a research setting) or of the patient (in a clinical setting). Some tests should be chosen for evaluating cognitive changes at high levels of cognition (FCSRT free-recall score/ delayed-free-recall score and verbal-fluency "category"), whereas others should be avoided because of their ceiling effect (FCSRT total-recall, DENO100).
Conversely, some tests seem more useful for evaluating cognitive changes at low levels of cognition (FCSRT total-recall score), while some should be avoided (WAIS-DST, TMT-A, SDOT). Another result of this study is that a majority of the scores exhibited strong curvilinearity. This curvilinearity could have consequences on the results of intervention trials or in epidemiological research 36 , and thus has to be taken into account in the analysis. In addition, this curvilinearity partly explains the remaining difficulties in providing a cut-off value for cognitive decline in the diagnosis of Prodromal-AD. Indeed, for most of the tests, a decrease of a given number of points will not have the same meaning according to the initial value of the score.
Thus it could be interesting to create an algorithm which would include different scores and/or different cut-off values to provide a prediction of the probability of developing AD rather than use a single test with a single cut-off value.
The improvement observed for some tests in MCI non-AD patients (FCRST, BVRT, DENO100) is probably due to practice and/or learning effects 37 . This kind of effect has been extensively documented in healthy participants for tasks assessing different cognitive functions including verbal episodic memory 38 . Contrary to some studies 37, 39 , the observed improvement was not limited to the second testing but was observed during the entire study (data not shown).
This effect is generally considered as an interfering variable complicating the interpretation of results 40 . However, it could also be considered as an interesting property which could help to differentiate the normal ability of an individual to learn and adjust with practice, from the pathological process of an individual with prodromal-AD.
Our statistical methodology has several advantages. It can handle unbalanced repeated measurements and bounded quantitative outcomes, and it can take into account and describe the metrological properties of neuropsychological tests 11 . However, it is worth noting that the latent cognitive process in this model is necessarily defined according to the pool of psychometric tests used in the analysis. In this study we used a large battery of neuropsychological tests which assessed several cognitive domains. Therefore, the modeled LCP could reasonably be interpreted as a global cognitive factor. However, a limitation of this study is that it was not designed to compare numerous different measures of a specific cognitive domain (like episodic memory), and hence cannot reasonably highlight one measure over others that were not tested.
Our study provides rational explanations for the selection of neuropsychological tests for the cognitive follow-up of patients with MCI in a clinical care context (for diagnostic or prognostic purposes of prodromal-AD) or research context (to identify a target population, or as an outcome for the effect of an early intervention in prodromal-AD). The tests that can be recommended are those which actually demonstrate a decline at the stage of prodromal-AD (the three FCSRT scores, the semantic verbal-fluency, the SDOT and the DENO100), and which are able to measure cognitive changes in the range of cognitive levels of the targeted population. In
Cognitive change in prodromal AD 16 the current study, the free-recall, the free-delayed-recall score (FCSRT) and the semantic verbalfluency test cover a wide cognitive range and seem to be adapted for the follow-up of subjects with an initial medium or high level of cognition. Conversely, the total-recall score (FCSRT) suffered from a very considerable ceiling effect, but appeared to be the best score for following up subjects with an initial low cognitive level. For future research, comparing several neuropsychological tests (or score) within a specific cognitive domain (particularly verbal episodic memory and language) using the same methodology could be of great interest for refining the choice of cognitive tests to be used. 
